Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and Outcomes

Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and Outcomes

Nobuko Hijiya,1,* Michael J Mauro2,* 1Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY, USA; 2Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY...

Full description

Bibliographic Details
Main Authors: Hijiya N, Mauro MJ
Format: Article
Language:English
Published: Dove Medical Press 2023-08-01
Series:Cancer Management and Research
Subjects:
asciminib
chronic myeloid leukemia
tyrosine kinase inhibitors
patient selection
pediatrics
Online Access:https://www.dovepress.com/asciminib-in-the-treatment-of-philadelphia-chromosome-positive-chronic-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/asciminib-in-the-treatment-of-philadelphia-chromosome-positive-chronic-peer-reviewed-fulltext-article-CMAR

Similar Items